Aeterna Zentaris to Present at BioContact in Québec City

QUÉBEC CITY, Sept. 26, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Senior Vice President and CFO, Dennis Turpin, CPA CA, will be presenting a corporate overview at BioContact on Wednesday, October 3, 2012, at 2 pm (Eastern), in the Grande-Allée Room of the Château Laurier Hotel in Québec City, Canada.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.

SOURCE: AETERNA ZENTARIS INC.

For further information:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com